ITMI20040795A1 - Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa - Google Patents
Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessaInfo
- Publication number
- ITMI20040795A1 ITMI20040795A1 IT000795A ITMI20040795A ITMI20040795A1 IT MI20040795 A1 ITMI20040795 A1 IT MI20040795A1 IT 000795 A IT000795 A IT 000795A IT MI20040795 A ITMI20040795 A IT MI20040795A IT MI20040795 A1 ITMI20040795 A1 IT MI20040795A1
- Authority
- IT
- Italy
- Prior art keywords
- itself
- pharmaceutical composition
- solid pharmaceutical
- dry solid
- water preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000795A ITMI20040795A1 (it) | 2004-04-23 | 2004-04-23 | Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa |
US11/578,661 US8252334B2 (en) | 2004-04-23 | 2005-04-21 | Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof |
JP2007508845A JP5285904B2 (ja) | 2004-04-23 | 2005-04-21 | 乾燥粉末医薬組成物、その製造方法、およびその組成物から得られる安定な水性懸濁液 |
PCT/EP2005/004277 WO2005102283A1 (en) | 2004-04-23 | 2005-04-21 | Dry powder pharmaceutical composition, its preparation process and stable aqueous suspension obtained from such composition |
ES05733765T ES2939532T3 (es) | 2004-04-23 | 2005-04-21 | Composición farmacéutica en polvo seco, su proceso de preparación y suspensión acuosa estable obtenida a partir de dicha composición |
PT57337651T PT1755558T (pt) | 2004-04-23 | 2005-04-21 | Composição farmacêutica de pó seco, o seu processo de preparação e suspensão aquosa estável obtida a partir de tal composição |
EP05733765.1A EP1755558B1 (en) | 2004-04-23 | 2005-04-21 | Dry powder pharmaceutical composition, its preparation process and stable aqueous suspension obtained from such composition |
US13/558,566 US20130052233A1 (en) | 2004-04-23 | 2012-07-26 | Dry Powder Pharmaceutical Compositions, Its Preparation Process and Stable Aqueous Suspension Obtained from such Composition |
US14/631,999 US20150202156A1 (en) | 2004-04-23 | 2015-02-26 | Dry powder pharmaceutical composition, its preparation process and stable aqueous suspension obtained from such composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000795A ITMI20040795A1 (it) | 2004-04-23 | 2004-04-23 | Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa |
Publications (1)
Publication Number | Publication Date |
---|---|
ITMI20040795A1 true ITMI20040795A1 (it) | 2004-07-23 |
Family
ID=34956435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000795A ITMI20040795A1 (it) | 2004-04-23 | 2004-04-23 | Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa |
Country Status (7)
Country | Link |
---|---|
US (3) | US8252334B2 (it) |
EP (1) | EP1755558B1 (it) |
JP (1) | JP5285904B2 (it) |
ES (1) | ES2939532T3 (it) |
IT (1) | ITMI20040795A1 (it) |
PT (1) | PT1755558T (it) |
WO (1) | WO2005102283A1 (it) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20051999A1 (it) | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
JP5113328B2 (ja) * | 2005-11-07 | 2013-01-09 | 田辺三菱製薬株式会社 | エマルション並びにそれを用いた目的物質粒子の製造方法及び医薬品 |
WO2008062475A2 (en) * | 2006-10-26 | 2008-05-29 | Cadila Healthcare Limited | Pharmaceutical compositions of ursodiol |
US20120149720A1 (en) * | 2010-07-30 | 2012-06-14 | Ranbaxy Laboratories Limited | Valacyclovir formulations |
US10183182B2 (en) | 2010-08-02 | 2019-01-22 | Guided Therapy Systems, Llc | Methods and systems for treating plantar fascia |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
WO2019126766A1 (en) * | 2017-12-21 | 2019-06-27 | Taiwan Liposome Co., Ltd. | Sustained-release triptan compositions and method of use the same through subdermal route or the like |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2269992A (en) * | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
US6001336A (en) * | 1996-12-31 | 1999-12-14 | Inhale Therapeutic Systems | Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof |
ATE287257T1 (de) | 1997-01-16 | 2005-02-15 | Massachusetts Inst Technology | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
US6946117B1 (en) * | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
ES2195408T5 (es) | 1997-09-29 | 2010-11-25 | Novartis Ag | Procedimiento de formación de polvo que comprende micropartículas perforadas. |
US6187765B1 (en) | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
IT1303692B1 (it) * | 1998-11-03 | 2001-02-23 | Chiesi Farma Spa | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
ITMI991582A1 (it) * | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
GB0107106D0 (en) * | 2001-03-21 | 2001-05-09 | Boehringer Ingelheim Pharma | Powder inhaler formulations |
US20040045546A1 (en) * | 2002-09-05 | 2004-03-11 | Peirce Management, Llc | Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use |
-
2004
- 2004-04-23 IT IT000795A patent/ITMI20040795A1/it unknown
-
2005
- 2005-04-21 JP JP2007508845A patent/JP5285904B2/ja active Active
- 2005-04-21 US US11/578,661 patent/US8252334B2/en active Active
- 2005-04-21 EP EP05733765.1A patent/EP1755558B1/en active Active
- 2005-04-21 PT PT57337651T patent/PT1755558T/pt unknown
- 2005-04-21 ES ES05733765T patent/ES2939532T3/es active Active
- 2005-04-21 WO PCT/EP2005/004277 patent/WO2005102283A1/en active Application Filing
-
2012
- 2012-07-26 US US13/558,566 patent/US20130052233A1/en not_active Abandoned
-
2015
- 2015-02-26 US US14/631,999 patent/US20150202156A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1755558T (pt) | 2023-03-02 |
US20150202156A1 (en) | 2015-07-23 |
EP1755558A1 (en) | 2007-02-28 |
WO2005102283A1 (en) | 2005-11-03 |
EP1755558B1 (en) | 2022-12-21 |
JP5285904B2 (ja) | 2013-09-11 |
US20070224276A1 (en) | 2007-09-27 |
US8252334B2 (en) | 2012-08-28 |
JP2007533694A (ja) | 2007-11-22 |
ES2939532T3 (es) | 2023-04-24 |
US20130052233A1 (en) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR22C1008I2 (fr) | Composition immunogène | |
CY2013035I1 (el) | Μεθοδοι χρησης συνθεσεων αμινοπυριδινης παρατεταμενης αποδεσμευσης | |
DK1962886T3 (da) | Stabile proteinformuleringer | |
DK1879844T3 (da) | Fremstilling af natriumdiformiat | |
DK1937824T3 (da) | Sammensætninger af tRNA og anvendelser deraf | |
DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
DK1720866T3 (da) | Fremgangsmåde | |
DE60311306D1 (de) | Feste poröse waschmittelzusammensetzungen | |
DE602006001995D1 (de) | Ansammlung von Teilchen | |
DK2377931T3 (da) | Varianter af glycosidhydrolase | |
DK1945745T3 (da) | Sur rengøringsmiddelsammensætning | |
DE502006004941D1 (de) | Von hohlprofilen | |
NO20043305D0 (no) | Preparation of lodixanol | |
NO20055643D0 (no) | Preparation of lodixanol | |
ITMI20040795A1 (it) | Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa | |
DK1973865T3 (da) | Fremstilling af natriumdiformat | |
ATE452142T1 (de) | Aufgereinigte arabinogalactanprotein-(agp- )zusammensetzung | |
DE602004015786D1 (de) | Waschmittelzusammensetzung | |
FR2890858B1 (fr) | Composition demaquillante | |
ITMI20040133A1 (it) | Processo per preparare fluoroalogenoeteri | |
ITMI20040132A1 (it) | Processo per preparare fluoroalogenoeteri | |
ITMI20040218A1 (it) | Uso di neridronato sodico per promuovere la neoformazione ossea | |
FI20050124A0 (fi) | Betonin lisäaine, sen valmistus ja käyttö, sekä menetelmä betonin valmistamiseksi ja betoni | |
FI6842U1 (fi) | Betonivaarnamuotti | |
ITRE20050141A1 (it) | "composizione insetticida solida sublimante" |